Jennifer Buell

VP Research & External Affairs, Agenus.

Companies

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

As of each latest filing. The line shows shares held over time.

Jan 2, 2026Shares withheld for tax 10,024 shares at $11.12 of MiNK Therapeutics, Inc.⁹
Jan 2, 2026Granted 31,474 shares at $11.12 of MiNK Therapeutics, Inc.¹¹
Sep 9, 2025Granted 18,229 shares at $15.36 of MiNK Therapeutics, Inc.¹²
Sep 9, 2025Shares withheld for tax 5,351 shares at $15.36 of MiNK Therapeutics, Inc.¹³
May 2, 2025Granted 581 shares at $3.11 of Agenus¹⁰
Apr 18, 2025Granted 869 shares at $2.08 of Agenus¹⁴
Apr 4, 2025Granted 1,159 shares at $1.56 of Agenus¹⁵
Mar 21, 2025Granted 1,123 shares at $1.61 of Agenus¹⁶
Mar 7, 2025Granted 409 shares at $2.35 of Agenus¹⁷
Feb 21, 2025Granted 545 shares at $3.32 of Agenus¹⁸
Feb 21, 2025Granted 626 shares at $3.32 of Agenus¹⁹
Feb 7, 2025Granted 516 shares at $3.50 of Agenus²⁰
Jan 24, 2025Shares withheld for tax 270 shares at $3.57 of Agenus²¹
Jan 24, 2025Granted 776 shares at $3.57 of Agenus²²
Oct 11, 2023Other 695,750 shares of MiNK Therapeutics, Inc.²³
Oct 3, 2023Shares withheld for tax 65,000 shares at $0.94 of MiNK Therapeutics, Inc.²⁴
Oct 2, 2023Shares withheld for tax 58,550 shares at $1.04 of MiNK Therapeutics, Inc.²⁴
Sep 29, 2023Shares withheld for tax 25,000 shares at $1.15 of MiNK Therapeutics, Inc.²⁴
Sep 27, 2023Exercised options 695,750 shares of MiNK Therapeutics, Inc.²⁵
Jan 9, 2023Granted 171,990 shares at $2.32 of MiNK Therapeutics, Inc.²⁶

The numbers on this page point here. Each one links to the record it came from.